About Us » Management Team

Management Team

  • Dr. Patrick Liu

    Chairman of GenScript Probio

    • Bachelor of Science in biochemistry and molecular biology from Nankai University in the PRC, Master’s degree in neurophysiology from Peking University in the PRC, and Doctor of Philosophy in neurobiology from University of Pittsburgh School of Medicine in the U.S.
    • Possesses over 14 years of R&D and management experience in the life-science and biologics development industry.
    • Appointed as the General Manager of the Reagent Service Business Unit of GenScript Biotech from September 2015 to April 2019, leading the rapid development and establishing GenScript's leading position in global market.
    • Served as the President of the Biosciences Group of GenScript Biotech from January 2017 to April 2019, responsible for formulating future strategic planning and development.
    • Appointed as the rotating Chief Executive Officer of GenScript Biotech in August 2020, responsible for strategic planning and execution, internal resource optimization and integration, and operational management.
    • As a core team member, led the formation of GenScript Probio, actively participating in and facilitating multiple rounds of financing for the company.
    • Appointed as Chairman of the Board of Directors of GenScript Probio in August 2022.
  • Dr. Li Chen

    Chief Executive Officer (CEO)

    • Ph.D in Molecular Biology and Biochemistry from Shanghai Institute of Biochemistry, Chinese Academy of Sciences,Bachelor of Biochemistry from Nanjing University
    • industrial experience began at Sigma-Aldrich, and successively held significant leadership positions at Millipore, Merck, and other companies
    • extensive experience in strategic business planning, operational excellence, and fostering robust businesses in various biotechnology fields
    • a decade working experience at Thermo Fisher Scientific, holding various key roles such as Vice President of China BID Business, Vice President of Asia-Pacific Region, and Vice President of Global Synthetic Biology. The high sensitivity to emerging technologies and market opportunities facilitated the successful transformation of the company's business, opening new growth paths and maintaining a leading position in the highly competitive industry
    • previously served as Vice President/General Manager of Biologics Business Unit at West Pharmaceutical Services in the United States and led the development and implementation of business expansion strategies across multiple areas, successfully achieving rapid growth of the company's business in the global market
  • Daniel Wang

    Chief Operating Officer (COO)

    • Rich experience in CRO and CDMO business operations, leading a team of more than 1,000 people
    • 10+ years' experience in team management, rich experience in multi-functional management such as production, R&D, business development and integrated operations
    • 14+ years' experience in protein expression and biologics development
    • Led the establishment of GenScript biologics CDMO platform and team; Led the establishment of GenScript biologics CDMO business unit.
  • Dr. Nathan Mao

    Chief Technology Officer (CTO)

    • 20+ years of experience in biologic drugs and vaccines development and cGMP manufacturing
    • Increasing management responsibilities at Biogen, Pfizer and Regeneron
    • Experience in both clinical & commercial manufacturing and support including ten commercially marketed medicines and blockbusters in U.S., EU and ROW
    • Leadership experience in building new modality programs such as Cell & Gene Therapy, viral and non-viral delivery systems, mRNA, siRNA, VLP, ADC, CRISPR/Cas9, LNP
    • Ph.D. from Brown University
  • Ben Chen

    Chief Quality Officer (CQO)

    • M.S. degree in Biotechnology Enterprise from Johns Hopkins University, Bachelor of Science in Chemical Engineering from Purdue University
    • Obtained a Professional Engineering license in the U.S., certified as a Six Sigma Green Belt and lean manufacturing
    • 28+ years of extensive biopharmaceutical experience in leading quality, manufacturing, and engineering professionals in the U.S., Europe, and Asia
    • Various positions of increasing responsibility at Genentech, Bristol-Myers Squibb, Novartis, Eli Lilly, Baxter, Impax and Wuxi Biologics before joining the company
  • Daniel Smith

    SVP of US Business Development

    • 20+ years of extensive biotech industry experience within Business Development, Field Sales Operations, Alliance Management, Global Operations, Global Supply Chain supporting U.S., Europe, and Asia markets
    • Pharmaceutical assignments include Amgen – CDMO Assignments include Samsung Biologics and Recipharm AB
    • 10+ years of Biologics manufacturing expertise for drug substance and drug product - development though commercialization
    • Post MBA - Marketing – California Lutheran University – Thousand Oaks, CA , MBA
    • Executive Management and BS Business Administration – University or LA Verne- La Verne California
  • Dr. Yu Liang

    VP of ADD Business Center

    • Ph.D. in Virology/Microbiology from the University of Chicago
    • Research Fellow, NIAID, NIH
    • PI/lab head, Novartis Inst. for Biomedical Research (Shanghai)
    • WuXi Biologics Discovery, Senior Project Leader and Portfolio Director
    • Over 20 years of research experience in biomedical science in academia and industry, with 10+ years of managerial experience in leading a global & multi-disciplinary project team in leading multinational pharmaceutical companies
    • Broad and in-depth knowledge & experience in early phase drug discovery of bio-therapeutics, with special expertise in the discovery of therapeutic modalities based on therapeutic Abs
  • Whitney Winters

    VP of Commercial Excellence Dept

    • 17+ years of experience leading strategic marketing and sales department in the biopharma and advanced therapies sector
    • Strong industry knowledge focused on identifying new trends in technology while providing market led solutions to pharmaceutical, biotech, advanced therapy and contract manufacturing organizations globally
    • Expertise in developing and executing effective marketing strategies, optimizing processes, and fostering sustainable growth
    • Proven ability to lead diverse teams, manage budgets, and drive global market penetration by creating a culture of accountability to drive revenue creation and profitability
    • Awarded a Master of Business Administration: Biotechnology & Health Industry Management in Pennsylvania State University Great Valley